Good morning. Elizabeth Cooney here in STAT’s Boston HQ, collaborating with Ed Silverman in San Francisco, where he has joined STAT’s corps of reporters covering the J.P. Morgan Healthcare Conference (or, as Ed refers to it, the annual Woodstock gathering for biopharma types). Here’s what we’re watching today, starting with that meeting:
A year after STAT found more men named Michael than female CEOs giving corporate presentations at the J.P. Morgan Healthcare Conference, the tables have turned, STAT reports. At this week’s confab, there will be 33 female CEOs presenting corporate updates, compared to 19 men named Michael. And yet women will still be massively outnumbered on one of biotech’s biggest stages: Men represent 90 percent of the 553 executives who will give corporate presentations at JPM. That’s down from 94 percent last year.
Talk about inflation … for drug prices?! Only in America would $8 Billion (with a ‘B’) describe the sale price for “a tiny company.” (Cf Lilly purchase of Loxo mentioned above)